Correlation Between Alector and Statera Biopharma
Can any of the company-specific risk be diversified away by investing in both Alector and Statera Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alector and Statera Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alector and Statera Biopharma, you can compare the effects of market volatilities on Alector and Statera Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alector with a short position of Statera Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alector and Statera Biopharma.
Diversification Opportunities for Alector and Statera Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Alector and Statera is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Alector and Statera Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Statera Biopharma and Alector is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alector are associated (or correlated) with Statera Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Statera Biopharma has no effect on the direction of Alector i.e., Alector and Statera Biopharma go up and down completely randomly.
Pair Corralation between Alector and Statera Biopharma
If you would invest (100.00) in Statera Biopharma on December 5, 2024 and sell it today you would earn a total of 100.00 from holding Statera Biopharma or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Alector vs. Statera Biopharma
Performance |
Timeline |
Alector |
Statera Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Alector and Statera Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Alector and Statera Biopharma
The main advantage of trading using opposite Alector and Statera Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alector position performs unexpectedly, Statera Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Statera Biopharma will offset losses from the drop in Statera Biopharma's long position.Alector vs. Passage Bio | Alector vs. Black Diamond Therapeutics | Alector vs. Revolution Medicines | Alector vs. Stoke Therapeutics |
Statera Biopharma vs. NeuroSense Therapeutics Ltd | Statera Biopharma vs. Acrivon Therapeutics, Common | Statera Biopharma vs. Alector | Statera Biopharma vs. Aadi Bioscience |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |